Aptose Biosciences (FRA:LTI) 3-Year EBITDA Growth Rate : 7.30% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences 3-Year EBITDA Growth Rate?

Aptose Biosciences's EBITDA per Share for the three months ended in Sep. 2024 was €-0.33.

During the past 3 years, the average EBITDA Per Share Growth Rate was 7.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aptose Biosciences was 41.30% per year. The lowest was -18.80% per year. And the median was 17.40% per year.

Competitive Comparison of Aptose Biosciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Aptose Biosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptose Biosciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's 3-Year EBITDA Growth Rate falls into.

Aptose Biosciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Aptose Biosciences (FRA:LTI) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Aptose Biosciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

APTO:USA 0UI8:UK LTI:Germany APS:Canada

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines